1. Home
  2. VOR vs TCI Comparison

VOR vs TCI Comparison

Compare VOR & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VOR
  • TCI
  • Stock Information
  • Founded
  • VOR 2015
  • TCI 1983
  • Country
  • VOR United States
  • TCI United States
  • Employees
  • VOR N/A
  • TCI N/A
  • Industry
  • VOR Biotechnology: Pharmaceutical Preparations
  • TCI Real Estate
  • Sector
  • VOR Health Care
  • TCI Finance
  • Exchange
  • VOR Nasdaq
  • TCI Nasdaq
  • Market Cap
  • VOR 202.4M
  • TCI 239.1M
  • IPO Year
  • VOR 2021
  • TCI N/A
  • Fundamental
  • Price
  • VOR $2.42
  • TCI $43.38
  • Analyst Decision
  • VOR Buy
  • TCI
  • Analyst Count
  • VOR 7
  • TCI 0
  • Target Price
  • VOR $3.77
  • TCI N/A
  • AVG Volume (30 Days)
  • VOR 47.5M
  • TCI 6.9K
  • Earning Date
  • VOR 08-07-2025
  • TCI 08-07-2025
  • Dividend Yield
  • VOR N/A
  • TCI N/A
  • EPS Growth
  • VOR N/A
  • TCI 59.61
  • EPS
  • VOR N/A
  • TCI 0.92
  • Revenue
  • VOR N/A
  • TCI $47,452,000.00
  • Revenue This Year
  • VOR N/A
  • TCI N/A
  • Revenue Next Year
  • VOR N/A
  • TCI N/A
  • P/E Ratio
  • VOR N/A
  • TCI $47.25
  • Revenue Growth
  • VOR N/A
  • TCI N/A
  • 52 Week Low
  • VOR $0.13
  • TCI $25.50
  • 52 Week High
  • VOR $3.29
  • TCI $46.74
  • Technical
  • Relative Strength Index (RSI)
  • VOR 73.52
  • TCI 55.85
  • Support Level
  • VOR $2.25
  • TCI $43.26
  • Resistance Level
  • VOR $2.84
  • TCI $46.23
  • Average True Range (ATR)
  • VOR 0.54
  • TCI 1.25
  • MACD
  • VOR 0.10
  • TCI -0.45
  • Stochastic Oscillator
  • VOR 70.92
  • TCI 18.64

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

Share on Social Networks: